U.S. Cryogenic Biobanking Services Market Forecast 2025–2030: Innovation Driven by Cord Blood Conservation and Personalized Medicine Industry Outlook & Forecast 2025-2030” from ResearchAndMarkets.com presents a comprehensive analysis of one of…
In March 2022, Nick De Graw, a 20-year-old sophomore majoring in mechanical engineering at the University of California, Irvine, noticed some unusual symptoms that led him to believe he might…
AbCellera Presents Promising Preclinical Data Demonstrating Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025 AbCellera Biologics Inc. (Nasdaq: ABCL), a leading technology company specializing in the discovery and…
Innate Pharma Presents Compelling Preclinical Data on Novel ADC Candidate IPH4502 Targeting Nectin-4 at AACR 2025 Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA), a biotechnology company specializing in the…
USPTO Invalidates Pharmacyclics Patent Challenged by BeiGene in BRUKINSA Dispute In a significant development in the ongoing intellectual property battle between two major players in the oncology therapeutics market, BeiGene,…
Xencor Reports Positive Interim Data From First-in-Human Study of XmAb942, Plans Phase 2b Trial for Inflammatory Bowel Disease Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company specializing in the development…
QIAGEN Expands Digital PCR Portfolio With Advanced Lentivirus Solutions to Elevate Quality Control in Cell and Gene Therapy Manufacturing QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA), a global leader in…
DEFINE-HT Clinical Trial Shows Prospera™ Heart Accurately Predicts Outcomes and Outperforms Biopsy in Heart Transplant Surveillance Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing,…
Guardant Health Unveils Compelling Data on Shield Multi-Cancer Detection Test at AACR 2025, Showcasing High Specificity and Sensitivity Across Ten Tumor Types Guardant Health, Inc. (Nasdaq: GH), a prominent leader…
Microba Life Sciences Achieves Breakthrough in IBD Diagnostics and Forms Strategic Partnership with Leading Gastroenterology Provider Microba Life Sciences Limited (ASX: MAP), a precision microbiome company at the forefront of…
D3 Bio Showcases Next-Generation KRAS G12C Inhibitor D3S-001 in Nature Medicine and AACR 2025 Presentation, Demonstrating Breakthrough Efficacy and Resistance Overcoming Potential D3 Bio, a clinical-stage biotechnology company at the…
InVitria Launches Optibumin® 25: A Groundbreaking 25% Recombinant Human Serum Albumin Designed for Closed-System Biomanufacturing InVitria, a recognized innovator in the development of recombinant, chemically defined components for biomanufacturing, has…